5년 이상 외래 치료를 받고 있는 조현병 환자의 약물 순응도에 영향을 미치는 요인
Factors Related to Medication Adherence in Outpatients with Schizophrenia under More Than 5 Years of Treatment
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
ObjectivesZZThis study aimed to investigate the medication adherence rate and related factors in chronic schizophrenia. MethodsZZA total of 65 (34 male and 31 female) outpatients with schizophrenia and with less than 5 years schizophrenia treatment were randomly selected to participate in the study survey. Medication adherence rate was evaluated by counting remaining tablets. The Korean version of Drug Attitude Inventory-10 (KDAI-10) was used to determine the subjective adherence rate. Adherence was defined as a patient taking more than 80% of their total prescribed medication. Positive KDAI-10 scores indicate good adherence. ResultsZZThe rate of good adherence was 87.7%. Our analysis showed that an older age (r=0.323, p=0.009), longer duration of illness (r=0.296, p=0.017), employment (F=4.41, p=0.016), remaining married (F=5.26, p=0.008), and being supported by family members, especially spouse or siblings (F=3.02, p=0.025) were significantly associated with good adherence. Presence of symptoms such as delusion (p=0.033) and hallucination (p=0.032) were related to poor adherence. ConclusionZZThe results indicate that future study should investigate patient characteristics associated with medication adherence and analyze the clinician/patient alliance and its affect on adherence. The results also show that further studies might be useful in developing and validating measures of adherence, as well as in designing and evaluating interventions to improve adherent behaviors.
Abstract
ObjectivesZZThis study aimed to investigate the medication adherence rate and related factors in chronic schizophrenia. MethodsZZA total of 65 (34 male and 31 female) outpatients with schizophrenia and with less than 5 years schizophrenia treatment were randomly selected to participate in the study survey. Medication adherence rate was evaluated by counting remaining tablets. The Korean version of Drug Attitude Inventory-10 (KDAI-10) was used to determine the subjective adherence rate. Adherence was defined as a patient taking more than 80% of their total prescribed medication. Positive KDAI-10 scores indicate good adherence. ResultsZZThe rate of good adherence was 87.7%. Our analysis showed that an older age (r=0.323, p=0.009), longer duration of illness (r=0.296, p=0.017), employment (F=4.41, p=0.016), remaining married (F=5.26, p=0.008), and being supported by family members, especially spouse or siblings (F=3.02, p=0.025) were significantly associated with good adherence. Presence of symptoms such as delusion (p=0.033) and hallucination (p=0.032) were related to poor adherence. ConclusionZZThe results indicate that future study should investigate patient characteristics associated with medication adherence and analyze the clinician/patient alliance and its affect on adherence. The results also show that further studies might be useful in developing and validating measures of adherence, as well as in designing and evaluating interventions to improve adherent behaviors.
참고문헌 (46)
- Barofsky I, "Compliance, adherence and the therapeutic alliance:steps in the development of self-care", Soc Sci Med, 12, pp.369~376 (1978)
- Boyd JR, "Drug defaulting. I. Determinants of compliance", Am J Hosp Pharm, 31, pp.362~367 (1974)
- Kane JM, "Treatment adherence and long-term outcomes", CNS Spectr, 12(10 Suppl 17), pp.21~26 (2007)
- Byerly MJ, "Antipsychotic medication adherence in schizophrenia", Psychiatr Clin North Am, 30, pp.437~452 (2007)
- Lacro JP, "Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature", J Clin Psychiatry, 63, pp.892~909 (2002)
- Kamali M, "A prospective evaluation of adherence to medication in first episode schizophrenia", Eur Psychiatry, 21, pp.29~33 (2006)
- Novak-Grubic V, "Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder", Eur Psychiatry, 17, pp.148~154 (2002)
- Linden M, "A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years", Schizophr Bull, 27, pp.585~596 (2001)
- Fenton WS, "Determinants of medication compliance in schizophrenia: empirical and clinical findings", Schizophr Bull, 23, pp.637~651 (1997)
- Robinson DG, "Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 156, pp.544~549 (1999)
- Blackwell B, "Treatment adherence", Br J Psychiatry, 129, pp.513~531 (1976)
- Stimson GV, "Obeying doctor’s orders: a view from the other side", Soc Sci Med, 8, pp.97~104 (1974)
- 박기국, "퇴원한 정신분열병 환자의 외래 통원 치료에 미치는 요인", 생물치료정신의학, 4(2), pp.210~222 (1998), 대한생물치료정신의학회
- Lee YH, "Factors on treatment compliance=illness behavior of schizophrenics under the long-term treatment", J Korean Neuropsychiatr Assoc, 28, pp.292~305 (1989)
- Kwon JS, "Medication compliance in psychiatric outpatients of a university hospital", J Korean Neuropsychiatr Assoc, 36, pp.523~529 (1997)
- Perkins DO, "Predictors of noncompliance in patients with schizophrenia", J Clin Psychiatry, 63, pp.1121~1128 (2002)
- Kampman O, "Compliance in psychoses", Acta Psychiatr Scand, 100, pp.167~175 (1999)
- Velligan DI, "The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness", J Clin Psychiatry, 70(Suppl 4), pp.1~46 (2009)
- Hogan TP, "A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity", Psychol Med, 13, pp.177~183 (1983)
- Hogan TP, "Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures", Psychol Med, 22, pp.347~352 (1992)
- 윤보현, "한국판 약물태도 척도의 심리측정적 특성", 대한정신약물학회지, 16(6), pp.480~487 (2005), 대한정신약물학회
- Colis MJ, "Cognitive insight in inpatients with psychotic, bipolar, and major depressive disorders", J. Psychopathol Behav Assess, 28, pp.243~250 (2006)
- 김유라, "정신분열병 환자의 인지적 병식에 관한 연구", Korean Journal of Clinical Psychology, 25(4), pp.1011~1027 (2006), 한국임상심리학회
- Gilmer TP, "Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia", Am J Psychiatry, 161, pp.692~699 (2004)
- Valenstein M, "Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review", J Clin Psychiatry, 67, pp.1542~1550 (2006)
- Nosé M, "How often do patients with psychosis fail to adhere to treatment programmes? A systematic review", Psychol Med, 33, pp.1149~1160 (2003)
- Jónsdóttir H, "Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level", J Clin Psychopharmacol, 30, pp.169~175 (2010)
- Dibonaventura M, "A patient perspective of the impact of medication side effects on adherence:results of a cross-sectional nationwide survey of patients with schizophrenia", BMC Psychiatry, 12, pp.20~ (2012)
- Adelufosi AO, "Medication adherence and quality of life among Nigerian outpatients with schizophrenia", Gen Hosp Psychiatry, 34, pp.72~79 (2012)
- Dassa D, "Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system", Aust N Z J Psychiatry, 44, pp.921~928 (2010)
- Waterreus A, "Medication for psychosis--consumption and consequences:the second Australian national survey of psychosis", Aust N Z J Psychiatry, 46, pp.762~773 (2012)
- Acosta FJ, "Medication adherence in schizophrenia", World J Psychiatry, 2, pp.74~82 (2012)
- Hui CL, "Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong", Keio J Med, 55, pp.9~14 (2006)
- Diaz E, "Effects of ethnicity on psychotropic medications adherence", Community Ment Health J, 41, pp.521~537 (2005)
- Remington G, "The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia", Schizophr Res, 90, pp.229~237 (2007)
- Nakonezny PA, "Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics", Schizophr Res, 82, pp.107~114 (2006)
- Ibrahim AW, "Prevalence and predictors of sub-optimal medication adherence among patients with severe mental illnesses in a tertiary psychiatric facility in Maiduguri, North-eastern Nigeria", Pan Afr Med J, 21, pp.39~ (2015)
- Draine J, "Explaining attitudes toward medication compliance among a seriously mentally ill population", J Nerv Ment Dis, 182, pp.50~54 (1994)
- Tehrani E, "Dropping out of psychiatric treatment: a prospective study of a first-admission cohort", Acta Psychiatr Scand, 94, pp.266~271 (1996)
- Krueger KP, "Improving adherence and persistence:a review and assessment of interventions and description of steps toward a national adherence initiative", J Am Pharm Assoc, 43, pp.668~678 (2003)
- Fleischhacker WW, "Factors influencing compliance in schizophrenia patients", J Clin Psychiatry, 64(Suppl 16), pp.10~13 (2003)
- Burton SC, "Strategies for improving adherence to second-generation antipsychotics in patients with schizophrenia by increasing ease of use", J Psychiatr Pract, 11, pp.369~378 (2005)
- Valenstein M, "Poor antipsychotic adherence among patients with schizophrenia:medication and patient factors", Schizophr Bull, 30, pp.255~264 (2004)
- Peuskens J, "Treatment retention with risperidone long-acting injection:24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries", Curr Med Res Opin, 26, pp.501~509 (2010)
- Acosta FJ, "Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables", Schizophr Res, 107, pp.213~217 (2009)
- Kane JM, "Review of treatments that can ameliorate nonadherence in patients with schizophrenia", J Clin Psychiatry, 67(Suppl 5), pp.9~14 (2006)